Midi Health has raised $100 million in a Series D round led by Goodwater Capital, lifting its valuation to more than $1 billion as it expands access to care for women across the U.S. The round also included Foresite Capital, Serena Ventures, and existing backers such as GV, Emerson Collective, and McKesson Ventures. Chief Executive Joanna Strober said, “This is validation for the movement we’re leading to provide women better healthcare,” adding, “Women’s health has been treated like an afterthought for too long. This funding gives us the resources to rewrite that story at scale.” The company now provides nationwide insurance coverage for more than 45 million women and serves over 25,000 patients each week across specialties, including OB-GYN, cardiology, endocrinology, and mental health.
The company uses artificial intelligence to support clinical decisions, automate scheduling and documentation, and analyze large datasets to improve treatment protocols. These tools have helped drive higher screening rates and lower overall care costs, alongside improvements in measures such as A1c and LDL. Goodwater’s Eric Kim said, “Goodwater is committed to Midi Health’s long-term mission to fundamentally transform women’s healthcare.” Serena Ventures Managing Partner, Serena Williams, added, “When women founders and women customers are heard, entire systems change.” To support growth, Midi has appointed Jason Wheeler as CFO, Melissa Waters as CMO, and Matt Cook as Chief Commercial Officer to strengthen financial, marketing, and commercial operations.
